Ulta profit skyrockets 178%
This article was originally published in The Rose Sheet
Executive Summary
In its fiscal first quarter ended May 1, specialty retailer Ulta posted earnings of $13.7 mil., up 177.7% from the same period last year due to a mix of market share growth, "dynamic" marketing for products and improved business operations, the Bolingbrook, Ill.-based firm announces June 3. Sales increased 19.1% to $320.2 mil. for the quarter. In its second fiscal quarter, Ulta will expand its prestige beauty offerings, introducing Philosophy skin-care, for example. Net sales for the period are expected to be in the range of $311 mil. to $317 mil., compared with net sales of $273.5 mil. in the second quarter of fiscal 2009
You may also be interested in...
Ulta Q2 Sales Shine Thanks To On-Trend Products, Traffic-Driving Events
Ulta Beauty charmed Wall Street with its Sept. 8 announcement of a fiscal 2011 second-quarter sales jump of 22.6% to $394.6 million, compared with the prior-year period.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.